PharmaForceIQ

PharmaForceIQ — HCP-level multichannel exposure-to-prescription attribution panel: per-NPI records of which advertisement, e-detailing piece, peer signal or field interaction an individual prescriber received and which downstream prescription, quality website visit or field activation it is credited with, spanning digital, personal and peer channels. Layered on top: patient-eligibility trigger signals (patient started or stopped therapy, content deployed within 24 hours), Next-Best-Action and affinity model outputs, and publisher-level engagement performance across 75,000+ publishers and 75+ …

PharmaForceIQ offers (Alternative, Sentiment, Supply Chain) — Very large exposure stream. Vendor-stated inventory: 75,000+ publishers, 75+ endemic specialist partners, and ~80% real-world data coverage implying reach across most of the US prescriber universe. Estimated ~10^8-10^9 exposure events monthly with NPI-level attribution retained against eligibility signals. The monthly rate is an inference from always-on campaign operation, not a vendor figure..

Life-sciences commercial: media-mix and channel-attribution modeling, prescriber-level Next-Best-Action model training, creative testing without a survey panel, promotional-spend ROI benchmarking. Machine learning: paired exposure/outcome records for uplift and causal-inference models, and creative-format ranking data for persuasive-content models. Advertising science generally: rare ground truth linking an advertisement to a measurable real-world behavior, a supervision signal transferable beyond pharma to any category where outcomes are observable.

The data is with 6 years of history.

Coverage spans US; Pharmaceuticals, Marketing; alternative, sentiment, supply_chain; equities.